Solute Carrier Family 45, Member 2 (SLC45A2) Peptid
SLC45A2
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle SLC45A2 Produkte
- SLC45A2 (Solute Carrier Family 45, Member 2 (SLC45A2))
- Protein-Typ
- Synthetic
- Spezies
- Säugetier
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequenz
- IGWTAFLSNM LFFTDFMGQI VYRGDPYSAH NSTEFLIYER GVEVGCWGFC
- Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC45 A2 antibody,
Alternative Names: SLC45A2 control peptide, SLC45A2 antibody Blocking Peptide, Anti-SLC45A2 Blocking Peptide, Solute Carrier Family 45 Member 2 Blocking Peptide, 1A1 Blocking Peptide, AIM1 Blocking Peptide, MATP Blocking Peptide, SLC45A2, SLCA2-45, SLCA2 45, SLCA2-45 Blocking Peptide, SLCA2 45 Blocking Peptide
-
-
- Applikationshinweise
- Optimal conditions should be determined by the investigator
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20 °C long term.
-
- Target
- SLC45A2 (Solute Carrier Family 45, Member 2 (SLC45A2))
- Hintergrund
- SLC45A2 is a melanocyte differentiation antigen that is expressed in a high percentage of melanoma cell lines. A similar sequence gene in medaka, 'B,' encodes a transporter that mediates melanin synthesis. Mutations in this gene are a cause of oculocutaneous albinism type 4.
- Molekulargewicht
- 51 kDa
-
Sie sind hier:
